Steris (STE) Tops Q3 EPS by 1c, Offers Guidance

Steris (NYSE: STE) reported Q3 EPS of $1.26, $0.01 better than the analyst estimate of $1.25. Revenue for the quarter came in at $696.2 million versus the consensus estimate of $688.4 million.

GUIDANCE:

Steris sees FY2019 EPS of $4.74-$4.84, versus the consensus of $4.76.

• The Company is maintaining its full year expectations for as reported revenue growth of approximately 5%, even though the impact of currency and divestitures has increased to approximately $35 million, with the impact of divestitures being about $25 million, and about $10 million of negative impact from currency based on the forward rates as of December 31, 2018. In addition, constant currency organic revenue growth is now expected to be approximately 6% for the full fiscal year 2019 reflecting the strong performance to date and expectations for the fourth quarter

For earnings history and earnings-related data on Steris (STE) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• XP Inc eyes US banking license as next business step
• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown